How does hypertension affect the elderly?
If high blood pressure isn’t controlled with lifestyle changes and medication, it can lead to serious health problems, including cardiovascular disease such as heart disease and stroke, vascular dementia, eye problems, and kidney disease.
What is the Sprint population?
AT A GLANCE. SPRINT included 9,361 adults age 50 or older who had systolic pressures of 130 mm Hg or higher and at least one other cardiovascular disease risk factor. Approximately 28 percent of the SPRINT population was age 75 or older and 28 percent had chronic kidney disease (CKD).
What is SHEP trial?
SHEP was a double-blind, randomized, placebo-controlled trial designed to test whether antihypertensive drug therapy reduces the frequency of new strokes in a multiethnic cohort of 4736 men and women aged 60 years or older with isolated systolic hypertension (SBP ≥160 mm Hg and diastolic blood pressure <90 mm Hg).
What is Sprint Trial hypertension?
The SPRINT Trial Clinical trials have shown that treatment of hypertension reduces the risk of cardiovascular disease outcomes, including incident stroke (by 35 to 40%), myocardial infarction (by 15 to 25%), and heart failure (by up to 64%). 5,15,16. However, the target for systolic blood-pressure lowering is uncertain …
Why was the sprint trial stopped?
This went on for more than three years, after which the trial was stopped because of a lower rate of the primary composite cardiovascular outcome in the intensive as compared to the standard treatment patients (-25%, P ≤ 0.001).
How long can you live with hypertension?
If left untreated, a blood pressure of 180/120 or higher results in an 80% chance of death within one year, with an average survival rate of ten months. Prolonged, untreated high blood pressure can also lead to heart attack, stroke, blindness, and kidney disease.
What was the main result of the accord BP trial?
The primary outcome for all three ACCORD trials was the first occurrence of a major cardiovascular event, which was defined as the composite of nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death.
Can I stop taking telmisartan?
If you stop taking it suddenly: Stopping this drug suddenly can cause your blood pressure to spike. This can increase your risk for heart attack or stroke. To reduce the risk of a heart attack, stroke, or death: Do not stop taking telmisartan without talking to your doctor.